Search for a command to run...
Rajnish Wellness Ltd. is positioned weakly compared to its peers, showing no revenue growth, zero profitability metrics, and a significant overvaluation relative to its financial performance. In contrast, other companies like Sun Pharmaceutical and Cipla exhibit strong growth and profitability, making them sector leaders. The analysis identifies potential value picks and highlights financially weak companies within the sector.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Rajnish Wellness Ltd. | ₹1.10 | ₹84.53Cr | 785.71 | - | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |